ANIX
Anixa Biosciences (ANIX)
$
85About Anixa Biosciences (ANIX)
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Details
Daily high
$3.03
Daily low
$2.83
Price at open
$2.97
52 Week High
$4.79
52 Week Low
$2.07
Market cap
95.8M
Dividend yield
0.00%
Volume
43,439
Avg. volume
159,539
P/E ratio
-7.56
Anixa Biosciences News
Details
Daily high
$3.03
Daily low
$2.83
Price at open
$2.97
52 Week High
$4.79
52 Week Low
$2.07
Market cap
95.8M
Dividend yield
0.00%
Volume
43,439
Avg. volume
159,539
P/E ratio
-7.56